Abstrakt
Objective: The majority of central nervous system tumors are diagnosed after clinical symptoms become apparent. The markers of survival prognosis in patients with gliomas are still evaluated.
In this study we attempt to analyze multiple factors associated with anti-tumor immunity to identify profiles associated with gliomas and their prognosis.
